Patients with Provoked Vestibulodynia (PVD) are Needed for a Randomized Controlled Trial

Patients with provoked vestibulodynia (PVD) are needed to test the efficacy of PelvicSense, a virtual skills-based program to manage pelvic pain and possibly vulvodynia. In this randomized controlled trial, the control group waits six months to do the program. It is our hope that PelvicSense will help vulvodynia patients manage their pain at home.

Study Overview

  • Potential participants complete a brief online eligibility screener (approximately 5 minutes)
  • Eligible participants are invited to complete a phone screening interview (20–30 minutes)
  • Participants then complete a baseline survey (approximately 30 minutes) and are randomized to receive the program either immediately or after a 6‑month wait period
  • Participants complete three brief check‑in surveys (weeks 3, 6, and 9; 5–10 minutes each), as well as two longer surveys (approximately 30 minutes each) at the end of the program and three months later

Eligibility Criteria

Participants must:

  • Have a healthcare provider diagnosis of provoked vestibulodynia
  • Be 18 years of age or older
  • Be able to read, speak, and write in English
  • Currently reside in Canada or the United States
  • Be willing to answer questions about PVD, sexual wellbeing, and their experience with the program

For more information please visit www.sexlab.ca/participate or email qshrl@queensu.ca.

This study has received ethical approval from the Queen’s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (HSREB).